bioMérieux S.A. (OTCMKTS:BMXMF) Short Interest Update

bioMérieux S.A. (OTCMKTS:BMXMF) saw a significant growth in short interest during the month of April. As of April 15th, there was short interest totalling 277,300 shares, a growth of 27.7% from the March 31st total of 217,200 shares. Based on an average trading volume of 100 shares, the short-interest ratio is presently 2,773.0 days.

bioMérieux Price Performance

Shares of bioMérieux stock opened at $105.67 on Tuesday. The firm has a 50 day simple moving average of $109.04 and a 200 day simple moving average of $106.31. bioMérieux has a fifty-two week low of $90.23 and a fifty-two week high of $115.25.

bioMérieux Company Profile

bioMérieux SA develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries.